Interventional Oncology Market Size, Share & Trends Analysis Report By Technique (Ablation Therapies, Embolization Therapies), By Procedure (Tumor Ablation, Tumor Biopsy), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 3 Business Days
Interventional Oncology Market Trends
The global interventional oncology market size was estimated at USD 4.09 billion in 2023 and is projected t%li%grow at a CAGR of 10.27% from 2024 t%li%2030. This growth can be attributed t%li%the increasing prevalence of cancer, increasing technological advancements in minimally invasive procedures, growing geriatric population, rising focus on early cancer detection, and increasing public and private investments in the field of interventional oncology. There is a significant rise in the number of cancer cases globally, increasing the need for advanced solutions facilitating better cancer care According t%li%the World Health Organization data published in February 2022, cancer accounted for around 10 million deaths in 2020, causing 1 in every 6 deaths globally.
The rising global incidence of cancer is largely attributed t%li%increasing tobacc%li%use, unhealthy diets, alcohol consumption, air pollution, and physical inactivity. This surge in cancer cases poses a significant challenge for healthcare systems, spurring the development of advanced solutions that offer better results and outcomes. Interventional oncology, which provides a minimally invasive alternative t%li%traditional cancer treatments such as surgery, radiation, and chemotherapy, has become increasingly popular. Its advantages in terms of reduced patient trauma and quicker recovery times are key factors driving market growth.
These staggering statistics highlight the urgent need for effective cancer treatments. Interventional oncology, with its array of minimally invasive techniques such as radiofrequency ablation (RFA), transarterial chemoembolization (TACE), and cryoablation, offers significant advantages over traditional surgery, including reduced recovery times and lower complication rates. As the global cancer burden continues t%li%rise, the adoption of these advanced interventional techniques is expected t%li%accelerate, driven by their ability t%li%improve patient outcomes and quality of life.
Companies in the interventional oncology market are actively pursuing various strategies t%li%develop advanced solutions aimed at improving patient treatment and care. For example, in April 2021, Terum%li%launched its global therapeutic interventional oncology team t%li%achieve excellence in interventional oncology solutions, with the goal of enhancing patient quality of life and survival rates. Such initiatives are expected t%li%spur the development of innovative solutions, increasing the adoption of interventional oncology and driving market growth.
Moreover, increased efforts t%li%develop advanced solutions have led t%li%significant investments from both government and private organizations. In June 2023, Royal Philips announced that the Philips-coordinated IMAGIO consortium of clinical partners received a grant of approximately $25.97 million. This funding is intended t%li%support research on minimally invasive cancer treatments, with a focus on liver cancer, lung cancer, and soft tissue sarcomas. Such investments are crucial for advancing interventional oncology technologies and improving patient outcomes.
Technique Insights
The ablation therapies segment held the largest market share in 2023. Ablation therapies, including radiofrequency, microwave, cryoablation, and laser ablation, are gaining popularity due t%li%their minimally invasive nature and their effectiveness in targeting tumours with minimal damage t%li%surrounding tissues. These therapies offer a promising alternative t%li%traditional cancer treatments such as surgery and radiation, providing patients with shorter recovery times, reduced pain, and fewer complications. With an increasing number of cancer cases each year, there is a growing demand for effective and less invasive treatment options. According t%li%the World Health Organization, cancer is one of the leading causes of death worldwide, and the number of new cases is expected t%li%rise significantly in the coming decades. This escalating burden of cancer is propelling the adoption of innovative treatment modalities like ablation therapies.
The embolization therapies segment is anticipated t%li%witness a significant CAGR over the forecast period. Embolization therapies, which involve the selective occlusion of blood vessels t%li%cut off the blood supply t%li%tumors, are increasingly recognized for their efficacy in treating various types of cancer, particularly liver cancer. These minimally invasive procedures offer significant advantages over traditional surgical approaches, including reduced recovery times, decreased complications, and the ability t%li%target tumors that are otherwise inoperable. The growing preference for minimally invasive procedures among patients and healthcare providers is als%li%contributing t%li%the market's expansion. Embolization therapies are typically performed on an outpatient basis, resulting in shorter hospital stays, lower healthcare costs, and quicker recovery times compared t%li%traditional surgery. This preference aligns with the broader trend towards cost-effective and patient-centric healthcare solutions, making embolization an attractive option for cancer treatment.
Global Interventional Oncology Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 t%li%2030. For this study, Grand View Research has segmented the global interventional oncology market report based on technique, procedure, application, end use, and region.
Interventional Oncology Market Trends
The global interventional oncology market size was estimated at USD 4.09 billion in 2023 and is projected t%li%grow at a CAGR of 10.27% from 2024 t%li%2030. This growth can be attributed t%li%the increasing prevalence of cancer, increasing technological advancements in minimally invasive procedures, growing geriatric population, rising focus on early cancer detection, and increasing public and private investments in the field of interventional oncology. There is a significant rise in the number of cancer cases globally, increasing the need for advanced solutions facilitating better cancer care According t%li%the World Health Organization data published in February 2022, cancer accounted for around 10 million deaths in 2020, causing 1 in every 6 deaths globally.
The rising global incidence of cancer is largely attributed t%li%increasing tobacc%li%use, unhealthy diets, alcohol consumption, air pollution, and physical inactivity. This surge in cancer cases poses a significant challenge for healthcare systems, spurring the development of advanced solutions that offer better results and outcomes. Interventional oncology, which provides a minimally invasive alternative t%li%traditional cancer treatments such as surgery, radiation, and chemotherapy, has become increasingly popular. Its advantages in terms of reduced patient trauma and quicker recovery times are key factors driving market growth.
These staggering statistics highlight the urgent need for effective cancer treatments. Interventional oncology, with its array of minimally invasive techniques such as radiofrequency ablation (RFA), transarterial chemoembolization (TACE), and cryoablation, offers significant advantages over traditional surgery, including reduced recovery times and lower complication rates. As the global cancer burden continues t%li%rise, the adoption of these advanced interventional techniques is expected t%li%accelerate, driven by their ability t%li%improve patient outcomes and quality of life.
Companies in the interventional oncology market are actively pursuing various strategies t%li%develop advanced solutions aimed at improving patient treatment and care. For example, in April 2021, Terum%li%launched its global therapeutic interventional oncology team t%li%achieve excellence in interventional oncology solutions, with the goal of enhancing patient quality of life and survival rates. Such initiatives are expected t%li%spur the development of innovative solutions, increasing the adoption of interventional oncology and driving market growth.
Moreover, increased efforts t%li%develop advanced solutions have led t%li%significant investments from both government and private organizations. In June 2023, Royal Philips announced that the Philips-coordinated IMAGIO consortium of clinical partners received a grant of approximately $25.97 million. This funding is intended t%li%support research on minimally invasive cancer treatments, with a focus on liver cancer, lung cancer, and soft tissue sarcomas. Such investments are crucial for advancing interventional oncology technologies and improving patient outcomes.
Technique Insights
The ablation therapies segment held the largest market share in 2023. Ablation therapies, including radiofrequency, microwave, cryoablation, and laser ablation, are gaining popularity due t%li%their minimally invasive nature and their effectiveness in targeting tumours with minimal damage t%li%surrounding tissues. These therapies offer a promising alternative t%li%traditional cancer treatments such as surgery and radiation, providing patients with shorter recovery times, reduced pain, and fewer complications. With an increasing number of cancer cases each year, there is a growing demand for effective and less invasive treatment options. According t%li%the World Health Organization, cancer is one of the leading causes of death worldwide, and the number of new cases is expected t%li%rise significantly in the coming decades. This escalating burden of cancer is propelling the adoption of innovative treatment modalities like ablation therapies.
The embolization therapies segment is anticipated t%li%witness a significant CAGR over the forecast period. Embolization therapies, which involve the selective occlusion of blood vessels t%li%cut off the blood supply t%li%tumors, are increasingly recognized for their efficacy in treating various types of cancer, particularly liver cancer. These minimally invasive procedures offer significant advantages over traditional surgical approaches, including reduced recovery times, decreased complications, and the ability t%li%target tumors that are otherwise inoperable. The growing preference for minimally invasive procedures among patients and healthcare providers is als%li%contributing t%li%the market's expansion. Embolization therapies are typically performed on an outpatient basis, resulting in shorter hospital stays, lower healthcare costs, and quicker recovery times compared t%li%traditional surgery. This preference aligns with the broader trend towards cost-effective and patient-centric healthcare solutions, making embolization an attractive option for cancer treatment.
Global Interventional Oncology Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 t%li%2030. For this study, Grand View Research has segmented the global interventional oncology market report based on technique, procedure, application, end use, and region.
- Technique Outlook (Revenue, USD Million, 2018 - 2030)
- Ablation Therapies
- Radiofrequency Ablation (RFA)
- Microwave Ablation (MWA)
- Cryoablation
- Laser Ablation
- Irreversible Electroporation (IRE)
- Embolization Therapies
- Transarterial Chemoembolization (TACE)
- Transarterial Radioembolization (TARE)
- Biopsy Techniques
- Core Needle Biopsy
- Fine Needle Aspiration (FNA)
- Targeted Therapy Delivery Systems
- Drug-Eluting Beads
- Radioembolization
- Drug-Eluting Stents
- Injectable Hydrogels and Nanoparticles
- Other Targeted Therapy Systems
- Image-Guided Procedures
- Ultrasound Guidance
- CT Scan Guidance
- MRI Guidance
- Fluoroscopy Guidance
- Procedure Outlook (Revenue, USD Million, 2018 - 2030)
- Tumor Ablation
- Tumor Biopsy
- Vascular Interventions
- Palliative Care
- Application Outlook (Revenue, USD Million, 2018 - 2030)
- Liver Cancer
- Lung Cancer
- Kidney Cancer
- Prostate Cancer
- Breast Cancer
- Other Cancer
- End Use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Specialty Clinics
- Others
- Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Thailand
- Latin America
- Brazil
- Argentina
- MEA
- South Africa
- Saudi Arabia
- UAE
- Kuwait
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Technique Segment
1.2.2. Procedure Segment
1.2.3. Application Segment
1.2.4. End Use Segment
1.3. Information analysis
1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
1.10.1. Objective
1.10.2. Objective
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
CHAPTER 3. INTERVENTIONAL ONCOLOGY MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of cancer
3.2.1.2. Increasing technological advancements in minimally invasive procedures
3.2.1.3. Growing geriatric population
3.2.1.4. Increasing focus on early cancer detection
3.2.1.5. Increasing public and private investments in the field of interventional oncology
3.2.2. Market restraint analysis
3.2.2.1. High cost associated with interventional oncology
3.2.2.2. Requirement of highly skilled professionals
3.3. Interventional Oncology Market Analysis Tools
3.3.1. Industry Analysis - Porter’s Five Forces
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
CHAPTER 4. INTERVENTIONAL ONCOLOGY MARKET: TECHNIQUE ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Global Interventional Oncology Market Product & Service Movement Analysis
4.3. Global Interventional Oncology Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Million)
4.4. Ablation Therapies
4.4.1. Ablation Therapies market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Radiofrequency Ablation (RFA)
4.4.2.1. Radiofrequency Ablation (RFA) market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Microwave Ablation (MWA)
4.4.3.1. Microwave Ablation (MWA) market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Cryoablation
4.4.4.1. Cryoablation market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5. Laser Ablation
4.4.5.1. Laser Ablation market estimates and forecasts 2018 to 2030 (USD Million)
4.4.6. Irreversible Electroporation (IRE)
4.4.6.1. Irreversible Electroporation (IRE) market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Embolization Therapies
4.5.1. Embolization Therapies market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2. Transarterial Chemoembolization (TACE)
4.5.2.1. Transarterial Chemoembolzation (TACE) market estimates and forecasts 2018 to 2030 (USD Million)
4.5.3. Transarterial Radioembolization (TARE)
4.5.3.1. Transarterial Radioembolization (TARE) market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Biopsy Techniques
4.6.1. Biopsy Techniques market estimates and forecasts 2018 to 2030 (USD Million)
4.6.2. Core Needle Biopsy
4.6.2.1. Core Needle Biopsy market estimates and forecasts 2018 to 2030 (USD Million)
4.6.3. Fine Needle Aspiration (FNA)
4.6.3.1. Fine Needle Aspiration (FNA) market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Targeted Therapy Delivery Systems
4.7.1. Drug Delivery Systems market estimates and forecasts 2018 to 2030 (USD Million)
4.7.2. Drug-Eluting Beads
4.7.2.1. Drug-Eluting Beads market estimates and forecasts 2018 to 2030 (USD Million)
4.7.3. Radioembolization
4.7.3.1. Radioembolization market estimates and forecasts 2018 to 2030 (USD Million)
4.7.4. Drug-Eluting Stents
4.7.4.1. Drug-Eluting Stents market estimates and forecasts 2018 to 2030 (USD Million)
4.7.5. Injectable Hydrogels and Nanoparticles
4.7.5.1. Injectable Hydrogels and Nanoparticles market estimates and forecasts 2018 to 2030 (USD Million)
4.7.6. Other Targeted Therapy Systems
4.7.6.1. Other Targeted Therapy Systems market estimates and forecasts 2018 to 2030 (USD Million)
4.8. Image-Guided Procedures
4.8.1. Image-Guided Procedures market estimates and forecasts 2018 to 2030 (USD Million)
4.8.2. Ultrasound Guidance
4.8.2.1. Ultrasound Guidance market estimates and forecasts 2018 to 2030 (USD Million)
4.8.3. CT Scan Guidance
4.8.3.1. CT Scan Guidance market estimates and forecasts 2018 to 2030 (USD Million)
4.8.4. MRI Guidance
4.8.4.1. MRI Guidance market estimates and forecasts 2018 to 2030 (USD Million)
4.8.5. Fluoroscopy Guidance
4.8.5.1. Fluoroscopy Guidance market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. INTERVENTIONAL ONCOLOGY MARKET: PROCEDURE ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Global Interventional Oncology Market Procedure Movement Analysis
5.3. Global Interventional Oncology Market Size & Trend Analysis, by Procedure, 2018 to 2030 (USD Million)
5.4. Tumor Ablation
5.4.1. Tumor Ablation market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Tumor Biopsy
5.5.1. Tumor Biopsy market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Vascular Interventions
5.6.1. Vascular Interventions market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Palliative Care
5.7.1. Palliative Care market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. INTERVENTIONAL ONCOLOGY MATERIALS MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Global Interventional Oncology Market Application Movement Analysis
6.3. Global Interventional Oncology Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
6.4. Liver Cancer
6.4.1. Liver Cancer market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Lung Cancer
6.5.1. Lung Cancer market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Kidney Cancer
6.6.1. Kidney Cancer market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Prostate Cancer
6.7.1. Prostate Cancer market estimates and forecasts 2018 to 2030 (USD Million)
6.8. Breast Cancer
6.8.1. Breast Cancer market estimates and forecasts 2018 to 2030 (USD Million)
6.9. Other Cancer
6.9.1. Other Cancer market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 7. INTERVENTIONAL ONCOLOGY MARKET: END USE ESTIMATES & TREND ANALYSIS
7.1. Segment Dashboard
7.2. Global Interventional Oncology Market End Use Movement Analysis
7.3. Global Interventional Oncology Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
7.4. Hospitals
7.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Specialty Clinics
7.5.1. Specialty Clinics market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Others
7.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 8. INTERVENTIONAL ONCOLOGY MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
8.1. Regional Market Share Analysis, 2023 & 2030
8.2. Regional Market Dashboard
8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030
8.4. North America
8.4.1. U.S.
8.4.1.1. Key country dynamics
8.4.1.2. Competitive scenario
8.4.1.3. Regulatory framework
8.4.1.4. Reimbursement scenario
8.4.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
8.4.2. Canada
8.4.2.1. Key country dynamics
8.4.2.2. Competitive scenario
8.4.2.3. Regulatory framework
8.4.2.4. Reimbursement scenario
8.4.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
8.4.3. Mexico
8.4.3.1. Key country dynamics
8.4.3.2. Competitive scenario
8.4.3.3. Regulatory framework
8.4.3.4. Reimbursement scenario
8.4.3.5. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
8.5. Europe
8.5.1. UK
8.5.1.1. Key country dynamics
8.5.1.2. Competitive scenario
8.5.1.3. Regulatory framework
8.5.1.4. Reimbursement scenario
8.5.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
8.5.2. Germany
8.5.2.1. Key country dynamics
8.5.2.2. Competitive scenario
8.5.2.3. Regulatory framework
8.5.2.4. Reimbursement scenario
8.5.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
8.5.3. France
8.5.3.1. Key country dynamics
8.5.3.2. Competitive scenario
8.5.3.3. Regulatory framework
8.5.3.4. Reimbursement scenario
8.5.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
8.5.4. Italy
8.5.4.1. Key country dynamics
8.5.4.2. Competitive scenario
8.5.4.3. Regulatory framework
8.5.4.4. Reimbursement scenario
8.5.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
8.5.5. Spain
8.5.5.1. Key country dynamics
8.5.5.2. Competitive scenario
8.5.5.3. Regulatory framework
8.5.5.4. Reimbursement scenario
8.5.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
8.5.6. Norway
8.5.6.1. Key country dynamics
8.5.6.2. Competitive scenario
8.5.6.3. Regulatory framework
8.5.6.4. Reimbursement scenario
8.5.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
8.5.7. Sweden
8.5.7.1. Key country dynamics
8.5.7.2. Competitive scenario
8.5.7.3. Regulatory framework
8.5.7.4. Reimbursement scenario
8.5.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
8.5.8. Denmark
8.5.8.1. Key country dynamics
8.5.8.2. Competitive scenario
8.5.8.3. Regulatory framework
8.5.8.4. Reimbursement scenario
8.5.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
8.6. Asia Pacific
8.6.1. Japan
8.6.1.1. Key country dynamics
8.6.1.2. Competitive scenario
8.6.1.3. Regulatory framework
8.6.1.4. Reimbursement scenario
8.6.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
8.6.2. China
8.6.2.1. Key country dynamics
8.6.2.2. Competitive scenario
8.6.2.3. Regulatory framework
8.6.2.4. Reimbursement scenario
8.6.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
8.6.3. India
8.6.3.1. Key country dynamics
8.6.3.2. Competitive scenario
8.6.3.3. Regulatory framework
8.6.3.4. Reimbursement scenario
8.6.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
8.6.4. Australia
8.6.4.1. Key country dynamics
8.6.4.2. Competitive scenario
8.6.4.3. Regulatory framework
8.6.4.4. Reimbursement scenario
8.6.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
8.6.5. South Korea
8.6.5.1. Key country dynamics
8.6.5.2. Competitive scenario
8.6.5.3. Regulatory framework
8.6.5.4. Reimbursement scenario
8.6.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
8.6.6. Thailand
8.6.6.1. Key country dynamics
8.6.6.2. Competitive scenario
8.6.6.3. Reimbursement scenario
8.6.6.4. Regulatory framework
8.6.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
8.7. Latin America
8.7.1. Brazil
8.7.1.1. Key country dynamics
8.7.1.2. Competitive scenario
8.7.1.3. Regulatory framework
8.7.1.4. Reimbursement scenario
8.7.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
8.7.2. Argentina
8.7.2.1. Key country dynamics
8.7.2.2. Competitive scenario
8.7.2.3. Regulatory framework
8.7.2.4. Reimbursement scenario
8.7.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
8.8. MEA
8.8.1. South Africa
8.8.1.1. Key country dynamics
8.8.1.2. Competitive scenario
8.8.1.3. Regulatory framework
8.8.1.4. Reimbursement scenario
8.8.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
8.8.2. Saudi Arabia
8.8.2.1. Key country dynamics
8.8.2.2. Competitive scenario
8.8.2.3. Regulatory framework
8.8.2.4. Reimbursement scenario
8.8.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
8.8.3. UAE
8.8.3.1. Key country dynamics
8.8.3.2. Competitive scenario
8.8.3.3. Regulatory framework
8.8.3.4. Reimbursement scenario
8.8.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
8.8.4. Kuwait
8.8.4.1. Key country dynamics
8.8.4.2. Competitive scenario
8.8.4.3. Regulatory framework
8.8.4.4. Reimbursement scenario
8.8.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 9. COMPETITIVE LANDSCAPE
9.1. Company/Competition Categorization
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2023
9.4. Company Profiles/Listing
9.4.1. Medtronic plc
9.4.1.1. Company overview
9.4.1.2. Financial performance
9.4.1.3. Product benchmarking
9.4.1.4. Strategic initiatives
9.4.2. Boston Scientific Corporation
9.4.2.1. Company overview
9.4.2.2. Financial performance
9.4.2.3. Product benchmarking
9.4.2.4. Strategic initiatives
9.4.3. Johnson & Johnson (Ethicon)
9.4.3.1. Company overview
9.4.3.2. Financial performance
9.4.3.3. Product benchmarking
9.4.3.4. Strategic initiatives
9.4.4. Baxter International Inc.
9.4.4.1. Company overview
9.4.4.2. Financial performance
9.4.4.3. Product benchmarking
9.4.4.4. Strategic initiatives
9.4.5. Cook Medical
9.4.5.1. Company overview
9.4.5.2. Financial performance
9.4.5.3. Product benchmarking
9.4.5.4. Strategic initiatives
9.4.6. C.R. Bard Inc. (Acquired by BD)
9.4.6.1. Company overview
9.4.6.2. Financial performance
9.4.6.3. Product benchmarking
9.4.6.4. Strategic initiatives
9.4.7. AngioDynamics Inc.
9.4.7.1. Company overview
9.4.7.2. Financial performance
9.4.7.3. Product benchmarking
9.4.7.4. Strategic initiatives
9.4.8. Stryker Corporation
9.4.8.1. Company overview
9.4.8.2. Financial performance
9.4.8.3. Product benchmarking
9.4.8.4. Strategic initiatives
9.4.9. B. Braun Melsungen AG
9.4.9.1. Company overview
9.4.9.2. Financial performance
9.4.9.3. Product benchmarking
9.4.9.4. Strategic initiatives
9.4.10. Terumo Corporation
9.4.10.1. Company overview
9.4.10.2. Financial performance
9.4.10.3. Product benchmarking
9.4.10.4. Strategic initiatives
9.4.11. Siemens Healthineers
9.4.11.1. Company overview
9.4.11.2. Financial performance
9.4.11.3. Product benchmarking
9.4.11.4. Strategic initiatives
9.4.12. GE Healthcare
9.4.12.1. Company overview
9.4.12.2. Financial performance
9.4.12.3. Product benchmarking
9.4.12.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Technique Segment
1.2.2. Procedure Segment
1.2.3. Application Segment
1.2.4. End Use Segment
1.3. Information analysis
1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
1.10.1. Objective
1.10.2. Objective
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
CHAPTER 3. INTERVENTIONAL ONCOLOGY MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of cancer
3.2.1.2. Increasing technological advancements in minimally invasive procedures
3.2.1.3. Growing geriatric population
3.2.1.4. Increasing focus on early cancer detection
3.2.1.5. Increasing public and private investments in the field of interventional oncology
3.2.2. Market restraint analysis
3.2.2.1. High cost associated with interventional oncology
3.2.2.2. Requirement of highly skilled professionals
3.3. Interventional Oncology Market Analysis Tools
3.3.1. Industry Analysis - Porter’s Five Forces
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
CHAPTER 4. INTERVENTIONAL ONCOLOGY MARKET: TECHNIQUE ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Global Interventional Oncology Market Product & Service Movement Analysis
4.3. Global Interventional Oncology Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Million)
4.4. Ablation Therapies
4.4.1. Ablation Therapies market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Radiofrequency Ablation (RFA)
4.4.2.1. Radiofrequency Ablation (RFA) market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Microwave Ablation (MWA)
4.4.3.1. Microwave Ablation (MWA) market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Cryoablation
4.4.4.1. Cryoablation market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5. Laser Ablation
4.4.5.1. Laser Ablation market estimates and forecasts 2018 to 2030 (USD Million)
4.4.6. Irreversible Electroporation (IRE)
4.4.6.1. Irreversible Electroporation (IRE) market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Embolization Therapies
4.5.1. Embolization Therapies market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2. Transarterial Chemoembolization (TACE)
4.5.2.1. Transarterial Chemoembolzation (TACE) market estimates and forecasts 2018 to 2030 (USD Million)
4.5.3. Transarterial Radioembolization (TARE)
4.5.3.1. Transarterial Radioembolization (TARE) market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Biopsy Techniques
4.6.1. Biopsy Techniques market estimates and forecasts 2018 to 2030 (USD Million)
4.6.2. Core Needle Biopsy
4.6.2.1. Core Needle Biopsy market estimates and forecasts 2018 to 2030 (USD Million)
4.6.3. Fine Needle Aspiration (FNA)
4.6.3.1. Fine Needle Aspiration (FNA) market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Targeted Therapy Delivery Systems
4.7.1. Drug Delivery Systems market estimates and forecasts 2018 to 2030 (USD Million)
4.7.2. Drug-Eluting Beads
4.7.2.1. Drug-Eluting Beads market estimates and forecasts 2018 to 2030 (USD Million)
4.7.3. Radioembolization
4.7.3.1. Radioembolization market estimates and forecasts 2018 to 2030 (USD Million)
4.7.4. Drug-Eluting Stents
4.7.4.1. Drug-Eluting Stents market estimates and forecasts 2018 to 2030 (USD Million)
4.7.5. Injectable Hydrogels and Nanoparticles
4.7.5.1. Injectable Hydrogels and Nanoparticles market estimates and forecasts 2018 to 2030 (USD Million)
4.7.6. Other Targeted Therapy Systems
4.7.6.1. Other Targeted Therapy Systems market estimates and forecasts 2018 to 2030 (USD Million)
4.8. Image-Guided Procedures
4.8.1. Image-Guided Procedures market estimates and forecasts 2018 to 2030 (USD Million)
4.8.2. Ultrasound Guidance
4.8.2.1. Ultrasound Guidance market estimates and forecasts 2018 to 2030 (USD Million)
4.8.3. CT Scan Guidance
4.8.3.1. CT Scan Guidance market estimates and forecasts 2018 to 2030 (USD Million)
4.8.4. MRI Guidance
4.8.4.1. MRI Guidance market estimates and forecasts 2018 to 2030 (USD Million)
4.8.5. Fluoroscopy Guidance
4.8.5.1. Fluoroscopy Guidance market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. INTERVENTIONAL ONCOLOGY MARKET: PROCEDURE ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Global Interventional Oncology Market Procedure Movement Analysis
5.3. Global Interventional Oncology Market Size & Trend Analysis, by Procedure, 2018 to 2030 (USD Million)
5.4. Tumor Ablation
5.4.1. Tumor Ablation market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Tumor Biopsy
5.5.1. Tumor Biopsy market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Vascular Interventions
5.6.1. Vascular Interventions market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Palliative Care
5.7.1. Palliative Care market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. INTERVENTIONAL ONCOLOGY MATERIALS MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Global Interventional Oncology Market Application Movement Analysis
6.3. Global Interventional Oncology Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
6.4. Liver Cancer
6.4.1. Liver Cancer market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Lung Cancer
6.5.1. Lung Cancer market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Kidney Cancer
6.6.1. Kidney Cancer market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Prostate Cancer
6.7.1. Prostate Cancer market estimates and forecasts 2018 to 2030 (USD Million)
6.8. Breast Cancer
6.8.1. Breast Cancer market estimates and forecasts 2018 to 2030 (USD Million)
6.9. Other Cancer
6.9.1. Other Cancer market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 7. INTERVENTIONAL ONCOLOGY MARKET: END USE ESTIMATES & TREND ANALYSIS
7.1. Segment Dashboard
7.2. Global Interventional Oncology Market End Use Movement Analysis
7.3. Global Interventional Oncology Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
7.4. Hospitals
7.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Specialty Clinics
7.5.1. Specialty Clinics market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Others
7.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 8. INTERVENTIONAL ONCOLOGY MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
8.1. Regional Market Share Analysis, 2023 & 2030
8.2. Regional Market Dashboard
8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030
8.4. North America
8.4.1. U.S.
8.4.1.1. Key country dynamics
8.4.1.2. Competitive scenario
8.4.1.3. Regulatory framework
8.4.1.4. Reimbursement scenario
8.4.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
8.4.2. Canada
8.4.2.1. Key country dynamics
8.4.2.2. Competitive scenario
8.4.2.3. Regulatory framework
8.4.2.4. Reimbursement scenario
8.4.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
8.4.3. Mexico
8.4.3.1. Key country dynamics
8.4.3.2. Competitive scenario
8.4.3.3. Regulatory framework
8.4.3.4. Reimbursement scenario
8.4.3.5. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
8.5. Europe
8.5.1. UK
8.5.1.1. Key country dynamics
8.5.1.2. Competitive scenario
8.5.1.3. Regulatory framework
8.5.1.4. Reimbursement scenario
8.5.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
8.5.2. Germany
8.5.2.1. Key country dynamics
8.5.2.2. Competitive scenario
8.5.2.3. Regulatory framework
8.5.2.4. Reimbursement scenario
8.5.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
8.5.3. France
8.5.3.1. Key country dynamics
8.5.3.2. Competitive scenario
8.5.3.3. Regulatory framework
8.5.3.4. Reimbursement scenario
8.5.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
8.5.4. Italy
8.5.4.1. Key country dynamics
8.5.4.2. Competitive scenario
8.5.4.3. Regulatory framework
8.5.4.4. Reimbursement scenario
8.5.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
8.5.5. Spain
8.5.5.1. Key country dynamics
8.5.5.2. Competitive scenario
8.5.5.3. Regulatory framework
8.5.5.4. Reimbursement scenario
8.5.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
8.5.6. Norway
8.5.6.1. Key country dynamics
8.5.6.2. Competitive scenario
8.5.6.3. Regulatory framework
8.5.6.4. Reimbursement scenario
8.5.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
8.5.7. Sweden
8.5.7.1. Key country dynamics
8.5.7.2. Competitive scenario
8.5.7.3. Regulatory framework
8.5.7.4. Reimbursement scenario
8.5.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
8.5.8. Denmark
8.5.8.1. Key country dynamics
8.5.8.2. Competitive scenario
8.5.8.3. Regulatory framework
8.5.8.4. Reimbursement scenario
8.5.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
8.6. Asia Pacific
8.6.1. Japan
8.6.1.1. Key country dynamics
8.6.1.2. Competitive scenario
8.6.1.3. Regulatory framework
8.6.1.4. Reimbursement scenario
8.6.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
8.6.2. China
8.6.2.1. Key country dynamics
8.6.2.2. Competitive scenario
8.6.2.3. Regulatory framework
8.6.2.4. Reimbursement scenario
8.6.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
8.6.3. India
8.6.3.1. Key country dynamics
8.6.3.2. Competitive scenario
8.6.3.3. Regulatory framework
8.6.3.4. Reimbursement scenario
8.6.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
8.6.4. Australia
8.6.4.1. Key country dynamics
8.6.4.2. Competitive scenario
8.6.4.3. Regulatory framework
8.6.4.4. Reimbursement scenario
8.6.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
8.6.5. South Korea
8.6.5.1. Key country dynamics
8.6.5.2. Competitive scenario
8.6.5.3. Regulatory framework
8.6.5.4. Reimbursement scenario
8.6.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
8.6.6. Thailand
8.6.6.1. Key country dynamics
8.6.6.2. Competitive scenario
8.6.6.3. Reimbursement scenario
8.6.6.4. Regulatory framework
8.6.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
8.7. Latin America
8.7.1. Brazil
8.7.1.1. Key country dynamics
8.7.1.2. Competitive scenario
8.7.1.3. Regulatory framework
8.7.1.4. Reimbursement scenario
8.7.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
8.7.2. Argentina
8.7.2.1. Key country dynamics
8.7.2.2. Competitive scenario
8.7.2.3. Regulatory framework
8.7.2.4. Reimbursement scenario
8.7.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
8.8. MEA
8.8.1. South Africa
8.8.1.1. Key country dynamics
8.8.1.2. Competitive scenario
8.8.1.3. Regulatory framework
8.8.1.4. Reimbursement scenario
8.8.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
8.8.2. Saudi Arabia
8.8.2.1. Key country dynamics
8.8.2.2. Competitive scenario
8.8.2.3. Regulatory framework
8.8.2.4. Reimbursement scenario
8.8.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
8.8.3. UAE
8.8.3.1. Key country dynamics
8.8.3.2. Competitive scenario
8.8.3.3. Regulatory framework
8.8.3.4. Reimbursement scenario
8.8.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
8.8.4. Kuwait
8.8.4.1. Key country dynamics
8.8.4.2. Competitive scenario
8.8.4.3. Regulatory framework
8.8.4.4. Reimbursement scenario
8.8.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 9. COMPETITIVE LANDSCAPE
9.1. Company/Competition Categorization
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2023
9.4. Company Profiles/Listing
9.4.1. Medtronic plc
9.4.1.1. Company overview
9.4.1.2. Financial performance
9.4.1.3. Product benchmarking
9.4.1.4. Strategic initiatives
9.4.2. Boston Scientific Corporation
9.4.2.1. Company overview
9.4.2.2. Financial performance
9.4.2.3. Product benchmarking
9.4.2.4. Strategic initiatives
9.4.3. Johnson & Johnson (Ethicon)
9.4.3.1. Company overview
9.4.3.2. Financial performance
9.4.3.3. Product benchmarking
9.4.3.4. Strategic initiatives
9.4.4. Baxter International Inc.
9.4.4.1. Company overview
9.4.4.2. Financial performance
9.4.4.3. Product benchmarking
9.4.4.4. Strategic initiatives
9.4.5. Cook Medical
9.4.5.1. Company overview
9.4.5.2. Financial performance
9.4.5.3. Product benchmarking
9.4.5.4. Strategic initiatives
9.4.6. C.R. Bard Inc. (Acquired by BD)
9.4.6.1. Company overview
9.4.6.2. Financial performance
9.4.6.3. Product benchmarking
9.4.6.4. Strategic initiatives
9.4.7. AngioDynamics Inc.
9.4.7.1. Company overview
9.4.7.2. Financial performance
9.4.7.3. Product benchmarking
9.4.7.4. Strategic initiatives
9.4.8. Stryker Corporation
9.4.8.1. Company overview
9.4.8.2. Financial performance
9.4.8.3. Product benchmarking
9.4.8.4. Strategic initiatives
9.4.9. B. Braun Melsungen AG
9.4.9.1. Company overview
9.4.9.2. Financial performance
9.4.9.3. Product benchmarking
9.4.9.4. Strategic initiatives
9.4.10. Terumo Corporation
9.4.10.1. Company overview
9.4.10.2. Financial performance
9.4.10.3. Product benchmarking
9.4.10.4. Strategic initiatives
9.4.11. Siemens Healthineers
9.4.11.1. Company overview
9.4.11.2. Financial performance
9.4.11.3. Product benchmarking
9.4.11.4. Strategic initiatives
9.4.12. GE Healthcare
9.4.12.1. Company overview
9.4.12.2. Financial performance
9.4.12.3. Product benchmarking
9.4.12.4. Strategic initiatives
LIST OF TABLES
Table 1 List of abbreviation
Table 2 Global interventional oncology market, by region, 2018 - 2030 (USD Million)
Table 3 Global interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 4 Global interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 5 Global interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 6 Global interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 7 North America interventional oncology market, by country, 2018 - 2030 (USD Million)
Table 8 North America interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 9 North America interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 10 North America interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 11 North America interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 12 U.S. interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 13 U.S. interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 14 U.S. interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 15 U.S. interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 16 Canada interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 17 Canada interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 18 Canada interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 19 Canada interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 20 Mexico interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 21 Mexico interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 22 Mexico interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 23 Mexico interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 24 Europe interventional oncology market, by country, 2018 - 2030 (USD Million)
Table 25 Europe interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 26 Europe interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 27 Europe interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 28 Europe interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 29 Germany interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 30 Germany interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 31 Germany interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 32 Germany interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 33 UK interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 34 UK interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 35 UK interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 36 UK interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 37 France interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 38 France interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 39 France interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 40 France interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 41 Italy interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 42 Italy interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 43 Italy interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 44 Italy interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 45 Spain interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 46 Spain interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 47 Spain interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 48 Spain interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 49 Denmark interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 50 Denmark interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 51 Denmark interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 52 Denmark interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 53 Sweden interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 54 Sweden interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 55 Sweden interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 56 Sweden interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 57 Norway interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 58 Norway interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 59 Norway interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 60 Norway interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 61 Asia Pacific interventional oncology market, by country, 2018 - 2030 (USD Million)
Table 62 Asia Pacific interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 63 Asia Pacific interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 64 Asia Pacific interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 65 Asia Pacific interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 66 China interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 67 China interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 68 China interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 69 China interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 70 Japan interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 71 Japan interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 72 Japan interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 73 Japan interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 74 India interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 75 India interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 76 India interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 77 India interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 78 South Korea interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 79 South Korea interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 80 South Korea interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 81 South Korea interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 82 Australia interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 83 Australia interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 84 Australia interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 85 Australia interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 86 Thailand interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 87 Thailand interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 88 Thailand interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 89 Thailand interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 90 Latin America interventional oncology market, by country, 2018 - 2030 (USD Million)
Table 91 Latin America interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 92 Latin America interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 93 Latin America interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 94 Latin America interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 95 Brazil interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 96 Brazil interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 97 Brazil interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 98 Brazil interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 99 Argentina interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 100 Argentina interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 101 Argentina interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 102 Argentina interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 103 MEA interventional oncology market, by country, 2018 - 2030 (USD Million)
Table 104 MEA interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 105 MEA interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 106 MEA interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 107 MEA interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 108 South Africa interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 109 South Africa interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 110 South Africa interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 111 South Africa interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 112 Saudi Arabia interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 113 Saudi Arabia interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 114 Saudi Arabia interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 115 Saudi Arabia interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 116 UAE interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 117 UAE interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 118 UAE interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 119 UAE interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 120 Kuwait interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 121 Kuwait interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 122 Kuwait interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 123 Kuwait interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 1 List of abbreviation
Table 2 Global interventional oncology market, by region, 2018 - 2030 (USD Million)
Table 3 Global interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 4 Global interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 5 Global interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 6 Global interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 7 North America interventional oncology market, by country, 2018 - 2030 (USD Million)
Table 8 North America interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 9 North America interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 10 North America interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 11 North America interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 12 U.S. interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 13 U.S. interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 14 U.S. interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 15 U.S. interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 16 Canada interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 17 Canada interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 18 Canada interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 19 Canada interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 20 Mexico interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 21 Mexico interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 22 Mexico interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 23 Mexico interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 24 Europe interventional oncology market, by country, 2018 - 2030 (USD Million)
Table 25 Europe interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 26 Europe interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 27 Europe interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 28 Europe interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 29 Germany interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 30 Germany interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 31 Germany interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 32 Germany interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 33 UK interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 34 UK interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 35 UK interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 36 UK interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 37 France interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 38 France interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 39 France interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 40 France interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 41 Italy interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 42 Italy interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 43 Italy interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 44 Italy interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 45 Spain interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 46 Spain interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 47 Spain interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 48 Spain interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 49 Denmark interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 50 Denmark interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 51 Denmark interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 52 Denmark interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 53 Sweden interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 54 Sweden interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 55 Sweden interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 56 Sweden interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 57 Norway interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 58 Norway interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 59 Norway interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 60 Norway interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 61 Asia Pacific interventional oncology market, by country, 2018 - 2030 (USD Million)
Table 62 Asia Pacific interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 63 Asia Pacific interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 64 Asia Pacific interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 65 Asia Pacific interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 66 China interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 67 China interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 68 China interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 69 China interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 70 Japan interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 71 Japan interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 72 Japan interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 73 Japan interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 74 India interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 75 India interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 76 India interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 77 India interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 78 South Korea interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 79 South Korea interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 80 South Korea interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 81 South Korea interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 82 Australia interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 83 Australia interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 84 Australia interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 85 Australia interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 86 Thailand interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 87 Thailand interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 88 Thailand interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 89 Thailand interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 90 Latin America interventional oncology market, by country, 2018 - 2030 (USD Million)
Table 91 Latin America interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 92 Latin America interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 93 Latin America interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 94 Latin America interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 95 Brazil interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 96 Brazil interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 97 Brazil interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 98 Brazil interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 99 Argentina interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 100 Argentina interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 101 Argentina interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 102 Argentina interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 103 MEA interventional oncology market, by country, 2018 - 2030 (USD Million)
Table 104 MEA interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 105 MEA interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 106 MEA interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 107 MEA interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 108 South Africa interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 109 South Africa interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 110 South Africa interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 111 South Africa interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 112 Saudi Arabia interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 113 Saudi Arabia interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 114 Saudi Arabia interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 115 Saudi Arabia interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 116 UAE interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 117 UAE interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 118 UAE interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 119 UAE interventional oncology market, by end use, 2018 - 2030 (USD Million)
Table 120 Kuwait interventional oncology market, by technique, 2018 - 2030 (USD Million)
Table 121 Kuwait interventional oncology market, by procedure, 2018 - 2030 (USD Million)
Table 122 Kuwait interventional oncology market, by application, 2018 - 2030 (USD Million)
Table 123 Kuwait interventional oncology market, by end use, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Tuberculosis Diagnostics Market Segmentation
Fig. 8 Market Snapshot, 2023
Fig. 9 Market Trends & Outlook
Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 14 Porter’s Five Forces Analysis
Fig. 15 Global Tuberculosis Diagnostics Market: Test Type Movement Analysis
Fig. 16 Global Tuberculosis Diagnostics Market, Nucleic Acid Testing, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 17 Global Tuberculosis Diagnostics Market, Detection of Latent Infection (Skin Test & IGRA), 2018 - 2030 (USD Million) (Number of Tests)
Fig. 18 Global Tuberculosis Diagnostics Market, Detection of Drug Resistance (DST), 2018 - 2030 (USD Million) (Number of Tests)
Fig. 19 Global Tuberculosis Diagnostics Market, Phage Assay, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 20 Global Tuberculosis Diagnostics Market, Cytokine Detection Assay, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 21 Global Tuberculosis Diagnostics Market, Diagnostic Laboratory Methods, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 22 Global Tuberculosis Diagnostics Market, Radiographic Method, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 23 Global Tuberculosis Diagnostics Market, Other Methods, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 24 Global Tuberculosis Diagnostics Market: End Use Movement Analysis
Fig. 25 Global Tuberculosis Diagnostics Market, for Diagnostics Laboratories, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 26 Global Tuberculosis Diagnostics Market, for Hospitals and Clinics, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 27 Global Tuberculosis Diagnostics Market, for Others, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 28 Regional Marketplace: Key Takeaways
Fig. 29 Regional Outlook, 2023 & 2030
Fig. 30 Global Tuberculosis Diagnostics Market: Region Movement Analysis
Fig. 31 North America Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 32 U.S. Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 33 Canada Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 34 Mexico Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 35 Europe Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 36 Germany Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 37 UK Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 38 France Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 39 Italy Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 40 Spain Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 41 Denmark Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 42 Sweden Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 43 Norway Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 44 Asia Pacific Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 45 Japan Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 46 China Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 47 India Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 48 Australia Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 49 South Korea Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 50 Thailand Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 51 Latin America Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 52 Brazil Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 53 Argentina Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 54 Middle East and Africa Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 55 South Africa Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 56 Saudi Arabia Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 57 UAE Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 58 Kuwait Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 1 Market research process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Tuberculosis Diagnostics Market Segmentation
Fig. 8 Market Snapshot, 2023
Fig. 9 Market Trends & Outlook
Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 14 Porter’s Five Forces Analysis
Fig. 15 Global Tuberculosis Diagnostics Market: Test Type Movement Analysis
Fig. 16 Global Tuberculosis Diagnostics Market, Nucleic Acid Testing, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 17 Global Tuberculosis Diagnostics Market, Detection of Latent Infection (Skin Test & IGRA), 2018 - 2030 (USD Million) (Number of Tests)
Fig. 18 Global Tuberculosis Diagnostics Market, Detection of Drug Resistance (DST), 2018 - 2030 (USD Million) (Number of Tests)
Fig. 19 Global Tuberculosis Diagnostics Market, Phage Assay, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 20 Global Tuberculosis Diagnostics Market, Cytokine Detection Assay, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 21 Global Tuberculosis Diagnostics Market, Diagnostic Laboratory Methods, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 22 Global Tuberculosis Diagnostics Market, Radiographic Method, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 23 Global Tuberculosis Diagnostics Market, Other Methods, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 24 Global Tuberculosis Diagnostics Market: End Use Movement Analysis
Fig. 25 Global Tuberculosis Diagnostics Market, for Diagnostics Laboratories, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 26 Global Tuberculosis Diagnostics Market, for Hospitals and Clinics, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 27 Global Tuberculosis Diagnostics Market, for Others, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 28 Regional Marketplace: Key Takeaways
Fig. 29 Regional Outlook, 2023 & 2030
Fig. 30 Global Tuberculosis Diagnostics Market: Region Movement Analysis
Fig. 31 North America Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 32 U.S. Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 33 Canada Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 34 Mexico Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 35 Europe Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 36 Germany Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 37 UK Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 38 France Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 39 Italy Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 40 Spain Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 41 Denmark Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 42 Sweden Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 43 Norway Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 44 Asia Pacific Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 45 Japan Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 46 China Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 47 India Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 48 Australia Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 49 South Korea Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 50 Thailand Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 51 Latin America Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 52 Brazil Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 53 Argentina Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 54 Middle East and Africa Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 55 South Africa Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 56 Saudi Arabia Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 57 UAE Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
Fig. 58 Kuwait Tuberculosis Diagnostics Market, 2018 - 2030 (USD Million) (Number of Tests)
